MedTrace Logo

Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine.

NCT04618146 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-01

No results posted yet for this study

Summary

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.

Conditions

  • Pain, Postoperative
  • Pruritus
  • Nausea, Postoperative
  • Vomiting, Postoperative

Interventions

DRUG

Morphine Sulfate

intrathecal low dose morphine for early return to normal activity without opioid related complications.

DRUG

Bupivacaine Hydrochloride

intrathecal bupivacaine 0.5%

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Sohair A Megalla, MD · Anesthesia and ICU department, Faculty of Medicine, Minia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-10
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04618146 on ClinicalTrials.gov